2019
DOI: 10.1039/c9mh00166b
|View full text |Cite
|
Sign up to set email alerts
|

Stimuli-responsive cyclodextrin-based nanoplatforms for cancer treatment and theranostics

Abstract: Stimuli-responsive cyclodextrin-based nanoplatforms, which can be triggered by different stimuli, such as pH, temperature, redox, enzymes, light and magnetic fields, are summarized for cancer treatment and theranostics.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
31
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(33 citation statements)
references
References 238 publications
0
31
0
Order By: Relevance
“…[12,14] Up to now hydrophobic drugs can be loaded in hydrogels by functionalizing their networks with hydrophobic domains like cyclodextrin or micelles. [15] This approach presents some drawbacks like the low amount of hydrophobic solute that can be loaded, [16] limiting the application to only drugs that exhibits high therapeutic activity even at low concentrations. Furthermore, Bijels can help overcome one of the main problems of nanomedicine: the uncontrolled distribution of nanoparticles though the body.…”
Section: Introductionmentioning
confidence: 99%
“…[12,14] Up to now hydrophobic drugs can be loaded in hydrogels by functionalizing their networks with hydrophobic domains like cyclodextrin or micelles. [15] This approach presents some drawbacks like the low amount of hydrophobic solute that can be loaded, [16] limiting the application to only drugs that exhibits high therapeutic activity even at low concentrations. Furthermore, Bijels can help overcome one of the main problems of nanomedicine: the uncontrolled distribution of nanoparticles though the body.…”
Section: Introductionmentioning
confidence: 99%
“…Current applications focus on site-specific drug/gene delivery and protein separation and analysis. Considering the avant-garde developments in CD chemistry, glycobiology and nanotechnology, a much broader range of progress is expected in the near future from their synergistic blend, including fields as diverse as catalysis [199,200], bioremediation [201], sensing [202][203][204][205], diagnostics [206,207], theranostics [208,209], vaccines [210,211] or personalized medicine [212,213]. Structures and schematic representation of the strategy developed by Riela, Lazzala and coworkers to assemble hybrid glycoCD/halloysite nanotubes to achieve functional glyconanomaterials for the co-administration of curcumin (Cur) and silibinin (Sil) in thyroid cancer cells [196,197].…”
Section: Discussionmentioning
confidence: 99%
“…62 CDs have hydrophilic and polar surface, due to the presence of the many hydroxyl groups. This dual-property opened the utilization of CDs in a wide range of areas, including water treatment, 63 separation, chromatography, 64,65 biomedical applications, 66,67 and catalysis. 68 In this section, we highlight the most significant studies of CDs for separation applications.…”
Section: Cyclodextrinsmentioning
confidence: 99%